scholarly article | Q13442814 |
P2093 | author name string | H Wang | |
J Dennis | |||
B Sherry | |||
H Schmidtmayerova | |||
L Dubrovsky | |||
P S Cohen | |||
K J Tracey | |||
M Bukrinsky | |||
P2860 | cites work | HIV accessory proteins: leading roles for the supporting cast. | Q40456339 |
An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role | Q40460832 | ||
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. | Q41147249 | ||
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group | Q45771512 | ||
Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques | Q46878044 | ||
Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. | Q52519672 | ||
Immunopathogenic mechanisms of HIV infection | Q71016167 | ||
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party | Q71523552 | ||
Molecular cloning of human p38 MAP kinase | Q72109756 | ||
TNF alpha regulation of HIV1: biology and therapy | Q72246651 | ||
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis | Q24311139 | ||
Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein | Q24564025 | ||
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family | Q24681172 | ||
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells | Q28237789 | ||
Phosphorylation of Vif and its role in HIV-1 replication | Q28278306 | ||
Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine | Q28287650 | ||
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B | Q29618096 | ||
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat | Q34295016 | ||
Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. | Q34323179 | ||
An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality | Q34367944 | ||
CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. | Q34380078 | ||
Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone | Q34381322 | ||
Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. | Q35858687 | ||
Gene expression as a target for new drug discovery. | Q40406770 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 339-346 | |
P577 | publication date | 1997-05-01 | |
P1433 | published in | Molecular Medicine | Q6895961 |
P1476 | title | The critical role of p38 MAP kinase in T cell HIV-1 replication | |
P478 | volume | 3 |
Q42475763 | Activation of MAP kinases in growth responsive pancreatic cancer cells |
Q35089872 | Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus |
Q44692673 | Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression |
Q92990096 | Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage |
Q39563540 | Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway |
Q50517258 | Evidence of a central role for p38 map kinase induction of tumor necrosis factor alpha in pancreatitis-associated pulmonary injury. |
Q38770059 | Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96. |
Q36735880 | Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules |
Q44704726 | G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer |
Q64038852 | Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines |
Q33565483 | Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy |
Q42075812 | Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail |
Q36526620 | Interleukin 18 stimulates HIV type 1 in monocytic cells |
Q24674569 | Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response |
Q35075468 | Microglial content-dependent inhibitory effects of calcitonin gene-related peptide (CGRP) on murine retroviral infection of glial cells. |
Q35023644 | Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. |
Q36950000 | Mitogen-activated protein kinase p38 in HIV infection and associated brain injury |
Q42732128 | Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter |
Q24338135 | Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation |
Q36666707 | Pathophysiology of pulmonary complications of acute pancreatitis |
Q28141445 | Phospholipases A2 in ischemic and toxic brain injury |
Q35553542 | Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents |
Q24562099 | Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells |
Q39550169 | Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. |
Q36489962 | Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro |
Q35063016 | Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor |
Q60692928 | Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation |
Q37781305 | Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response. |
Q34124131 | Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release |
Q39538222 | Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection |
Q45040278 | The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. |
Q37541047 | The multi-target effects of CNI-1493: convergence of anti-amylodogenic and anti-inflammatory properties in animal models of Alzheimer's disease |
Q34463802 | The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy |
Q36291699 | The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria |
Q34133579 | Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities |
Q22253886 | Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors |
Q40380418 | Tumor necrosis factor as a pharmacological target. |
Q38181142 | Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. |
Q35968487 | Viral hijacking of G-protein-coupled-receptor signalling networks. |
Q34358595 | Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology |
Q34483284 | p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. |
Q40310541 | p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation |
Q81573121 | p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury |
Search more.